Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Synopsys, Inc.    SNPS   US8716071076

SYNOPSYS, INC.

 (SNPS)

0
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

SYNOPSYS : Posts Financial Results for Second Quarter Fiscal Year 2010

05/19/2010| 04:20pm US/Eastern
Recommend:
0

MOUNTAIN VIEW, Calif., May 19 /PRNewswire-FirstCall/ -- Synopsys, Inc. (Nasdaq: SNPS), a world leader in software and IP for semiconductor design, verification and manufacturing, today reported results for its second quarter of fiscal year 2010.

For the second quarter of fiscal 2010, Synopsys reported revenue of $338.1 million compared to $336.8 million for the second quarter of fiscal 2009.

"Synopsys again delivered solid results this quarter, " said Aart de Geus, chairman and CEO of Synopsys. "While the customer backdrop remains cautious, we continue to execute well on our strategy to address customer needs ranging from mainstream to the most advanced silicon design flows, all the way to the rapidly growing IP and systems space. This quarter we made particular progress in the latter, where we believe we have an especially promising outlook."

GAAP Results

On a generally accepted accounting principles (GAAP) basis, net income for the second quarter of fiscal 2010 was $39.5 million, or $0.26 per share, compared to $48.3 million, or $0.33 per share, for the second quarter of fiscal 2009.

Non-GAAP Results

On a non-GAAP basis, net income for the second quarter of fiscal 2010 was $61.9 million, or $0.41 per share, compared to non-GAAP net income of $65.9 million, or $0.45 per share, for the second quarter of fiscal 2009.

Financial Targets

Synopsys also provided its financial targets for the third quarter and full fiscal year 2010. These targets do not include future acquisition-related expenses that may be incurred in fiscal 2010. These targets constitute forward-looking information and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see "Forward-Looking Statements" below.

Third Quarter of Fiscal Year 2010 Targets:

    --  Revenue: $330 million - $338 million
    --  GAAP expenses: $275 million - $292 million
    --  Non-GAAP expenses: $251 million - $261 million
    --  Other income and expense: $0 - $3 million
    --  Tax rate applied in non-GAAP net income calculations: approximately 27
        percent
    --  Fully diluted outstanding shares: 149 million - 154 million
    --  GAAP earnings per share: $0.21 - $0.27
    --  Non-GAAP earnings per share: $0.36 - $0.38
    --  Revenue from backlog: greater than 90 percent

Full-Year Fiscal Year 2010 Targets:

    --  Revenue: $1.340 billion - $1.355 billion
    --  Other income and expense: $4 million - $8 million
    --  Tax rate applied in non-GAAP net income calculations: approximately 27
        percent
    --  Fully diluted outstanding shares: 149 million - 154 million
    --  GAAP earnings per share: $1.56 - $1.75
    --  Non-GAAP earnings per share: $1.52 - $1.62
    --  Cash flow from operations: $205 million - $225 million

GAAP Reconciliation

Synopsys continues to provide all information required in accordance with GAAP, but believes evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its ongoing business operations and what Synopsys uses to evaluate its ongoing operations and for internal planning and forecasting purposes. Synopsys' management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Synopsys' management believes it is useful for itself and investors to review, as applicable, both GAAP information that includes: (i) the amortization of acquired intangible assets; (ii) the impact of stock compensation; (iii) in-process research and development expenses, (iv) acquisition-related costs; (v) other significant items, including the effect of a tax benefit from a settlement with the Internal Revenue Service, and (vi) the income tax effect of non-GAAP pre-tax adjustments from the provision for income taxes; and the non-GAAP measures that exclude such information in order to assess the performance of Synopsys' business and for planning and forecasting in subsequent periods. Whenever Synopsys uses such a non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed below.

Reconciliation of Second Quarter Fiscal Year 2010 Results

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income and earnings per share for the periods indicated below.


      GAAP to Non-GAAP Reconciliation of Second Quarter Fiscal Year 2010
                                    Results
            (unaudited and in thousands, except per share amounts)


                                 Three Months
                                    Ended              Six Months Ended
                                  April 30,                April 30,
                                  ---------                ---------
                              2010         2009      2010          2009
                              ----         ----      ----          ----
    GAAP net income        $39,549      $48,288  $172,335      $100,717
    Adjustments:
        Amortization of
         intangible assets  11,814       10,620    22,464        22,428
        Stock compensation  13,466       14,661    30,700        28,804
        In-process
         research and
         development             -            -         -           600
        Acquisition-
         related costs       6,120            -     7,166             -
        Tax benefit from
         IRS settlement          -            -  (91,649)             -
        Tax effect         (9,015)      (7,666)  (16,663)      (15,050)
                            ------                -------
    Non-GAAP net income    $61,934      $65,903  $124,353      $137,499
                           =======      =======  ========      ========



                               Three Months
                                  Ended          Six Months Ended
                                April 30,            April 30,
                                ---------            ---------
                              2010         2009      2010          2009
                              ----         ----      ----          ----
    GAAP net income per
     share                   $0.26        $0.33     $1.14         $0.70
    Adjustments:
        Amortization of
         intangible assets    0.08         0.07      0.15          0.16
        Stock compensation    0.09         0.10      0.20          0.19
        In-process
         research and
         development             -            -         -          0.01
        Acquisition-
         related costs        0.04            -      0.05             -
        Tax benefit from
         IRS settlement          -            -     (0.61)            -
        Tax effect           (0.06)       (0.05)    (0.11)        (0.11)
    Non-GAAP net
     income per share        $0.41        $0.45     $0.82         $0.95
                             =====        =====     =====         =====

    Shares used in
     calculation           152,482      145,421   151,635       144,024

Reconciliation of Target Operating Results

The following tables reconcile the specific items excluded from GAAP in the calculation of target non-GAAP operating results for the periods indicated below:



         GAAP to non-GAAP Reconciliation of Third Quarter Fiscal Year
                                 2010 Targets
                   (in thousands, except per share amounts)

                                                        Range for Three
                                                             Months
                                                        Ending July 31,
                                                              2010
                                                       ----------------
                                                      Low          High
                                                      ---          ----
    Target GAAP expenses                           $275,000      $292,000
    Adjustment:
           Estimated impact of amortization of
            intangible assets                      (10,000)      (13,000)
           Estimated impact of stock compensation  (14,000)      (18,000)
    Target non-GAAP expenses                       $251,000      $261,000
                                                   ========      ========



                                                      Range for Three
                                                           Months
                                                      Ending July 31,
                                                              2010
                                                       ----------------
                                                      Low          High
                                                      ---          ----
    Target GAAP earnings per share                    $0.21         $0.27
    Adjustment:
        Estimated impact of amortization of
         intangible assets                             0.09          0.06
        Estimated impact of stock compensation         0.12          0.09
        Net non-GAAP tax effect                       (0.06)        (0.04)
    Target non-GAAP earnings per share                $0.36         $0.38
                                                      =====         =====

    Shares used in non-GAAP calculation
     (midpoint of target range)                     151,500       151,500





        GAAP to Non-GAAP Reconciliation of Fiscal Year 2010 Targets

                                                     Range for Fiscal
                                                            Year
                                                    Ending October 31,
                                                              2010
                                                     -------------------
                                                      Low          High
                                                      ---          ----
    Target GAAP earnings per share                    $1.56         $1.75
    Adjustment:
        Estimated impact of amortization of
         intangible assets                             0.33          0.26
        Estimated impact of stock compensation         0.40          0.35
        Acquisition-related costs                      0.05          0.05
        Tax benefit from IRS settlement               (0.61)        (0.61)
        Net non-GAAP tax effect                       (0.21)        (0.18)
    Target non-GAAP earnings per share                $1.52         $1.62
                                                      =====         =====

    Shares used in non-GAAP calculation
     (midpoint of target range)                     151,500       151,500

Earnings Call Open to Investors

Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m., Pacific Time. A live webcast of the call will be available at Synopsys' corporate website at www.synopsys.com. A recording of the call will be available by calling +1-800-475-6701 (+1-320-365-3844 for international callers), access code 156545, beginning at 4:00 p.m. Pacific Time today. A webcast replay will also be available on the website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the third quarter fiscal 2010 in August 2010. Synopsys will post copies of the prepared remarks of Aart de Geus, chairman and chief executive officer, and Brian Beattie, chief financial officer, on its website following the call. In addition, Synopsys makes additional financial information available in a financial supplement also posted on the corporate website.

Effectiveness of Information

The targets included in this release, the statements made during the earnings conference call and the information contained in the financial supplement (available in the Investor Relations section of Synopsys' website at www.synopsys.com) represent Synopsys' expectations and beliefs as of the date of this release only. Although this press release, copies of the prepared remarks of the chief executive officer and chief financial officer made during the call and the financial supplement will remain available on Synopsys' website through the date of the third quarter fiscal 2010 earnings call in August 2010, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys does not currently intend to report on its progress during the third quarter of fiscal 2010 or comment to analysts or investors on, or otherwise update, the targets given in this earnings release.

Availability of Final Financial Statements

Synopsys will include final financial statements for the second quarter fiscal 2010 in its quarterly report on Form 10-Q to be filed by June 10, 2010.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is a world leader in electronic design automation (EDA), supplying the global electronics market with the software, intellectual property (IP) and services used in semiconductor design, verification and manufacturing. Synopsys' comprehensive, integrated portfolio of implementation, verification, IP, manufacturing and field-programmable gate array (FPGA) solutions helps address the key challenges designers and manufacturers face today, such as power and yield management, software-to-silicon verification and time-to-results. These technology-leading solutions help give Synopsys customers a competitive edge in bringing the best products to market quickly while reducing costs and schedule risk. Synopsys is headquartered in Mountain View, California, and has more than 65 offices located throughout North America, Europe, Japan, Asia and India. Visit Synopsys online at http://www.synopsys.com.

Forward-Looking Statements

The statements made in this press release regarding projected financial results in the sections entitled "Financial Targets," and "Reconciliation of Target Operating Results" and certain statements made in the earnings conference call are forward-looking statements within the meaning of the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934. Actual results could differ materially from those described by these statements due to a number of uncertainties, including, but not limited to:

    --  continued uncertainty in the global economy in general, and weakness in
        the semiconductor and electronics industries;
    --  failure of customers to pay license fees as scheduled;
    --  lower-than-expected research and development spending by semiconductor
        and electronic systems companies;
    --  competition in the market for Synopsys' products and services;
    --  lower-than-anticipated new IC design starts;
    --  lower-than-anticipated purchases or delays in purchases of software or
        consulting services by Synopsys' customers, including delays in the
        renewal, or non-renewal, of Synopsys' license arrangements with major
        customers;
    --  changes in the mix of time-based licenses and upfront licenses;
    --  lower-than-expected orders; and
    --  difficulties in the integration of the products and operations of
        acquired companies or assets into Synopsys' products and operations.

In addition, Synopsys' actual expenses, earnings per share and tax rate on a GAAP and non-GAAP basis for the fiscal quarter ending July 31, 2010 and actual expenses, earnings per share, tax rate, cash flow from operations and other projections on a GAAP and non-GAAP basis for fiscal year 2010 could differ materially from the targets stated under "Financial Targets" above for a number of reasons, including, but not limited to, (i) a determination by Synopsys that any portion of its goodwill or intangible assets have become impaired, (ii) application of the actual consolidated GAAP and non-GAAP tax rates for such periods, or judgment by management, based upon the status of pending audits and settlements to increase or decrease an income tax asset or liability, (iii) integration and other acquisition-related costs including amortization of intangible assets and costs formerly capitalized but now expensed due to new accounting guidance related to business combinations, (iv) changes in the anticipated amount of employee stock compensation expense recognized on Synopsys' financial statements, (v) actual change in the fair value of Synopsys' non-qualified deferred compensation plan obligations, (vi) increases or decreases to estimated capital expenditures, (vii) changes driven by new accounting rules, regulations, interpretations or guidance, (viii) general economic conditions, and (ix) other risks as detailed in our SEC filings, including those described in the "Risk Factors" section in our latest Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2010. Furthermore, Synopsys' actual tax rates applied to income for the third quarter and fiscal year 2010 could differ from the targets given in this press release as a result of a number of factors, including the actual geographic mix of revenue during the quarter and year, and actions by the government. Finally, Synopsys' targets for outstanding shares in the third quarter and fiscal year 2010 could differ from the targets given in this press release as a result of higher than expected employee stock plan issuances or stock option exercises, acquisitions and the extent of Synopsys' stock repurchase activity.

Synopsys is under no obligation to (and expressly disclaims any such obligation to) update or alter any of the forward-looking statements made in this earnings release, the conference call or the financial supplement whether as a result of new information, future events or otherwise, unless otherwise required by law.

Synopsys is a registered trademark of Synopsys, Inc. Any other trademarks mentioned in this release are the property of their respective owners.


                                             SYNOPSYS, INC.
                           Unaudited Consolidated Statements of Operations (1)
                                (in thousands, except per share amounts)

                               Three Months Ended           Six Months Ended
                                    April 30,                   April 30,
                               ------------------        ----------------
                              2010         2009 (2)     2010         2009 (2)
                              ----          -------     ----          -------
    Revenue:
      Time-based license  $288,672         $287,315 $561,147         $574,991
      Upfront license       12,715           12,675   33,161           28,378
      Maintenance and
       service              36,719           36,845   73,965           73,221
                            ------           ------   ------           ------
          Total revenue    338,106          336,835  668,273          676,590
    Cost of revenue:
      License               44,930           42,292   86,144           84,115
      Maintenance and
       service              15,268           15,048   31,778           30,627
      Amortization of
       intangible assets     8,829            7,679   16,686           15,701
         Total cost of
          revenue           69,027           65,019  134,608          130,443
    Gross margin           269,079          271,816  533,665          546,147
    Operating expenses:
      Research and
       development         113,050          102,996  214,282          200,803
      Sales and marketing   79,363           82,520  158,979          159,904
      General and
       administrative       28,713           28,691   54,566           55,873
      In-process research
       and development           -                -        -              600
      Amortization of
       intangible assets     2,985            2,941    5,778            6,727
         Total operating
          expenses         224,111          217,148  433,605          423,907
    Operating income        44,968           54,668  100,060          122,240
    Other income, net        8,905           10,445   11,155           12,544
                             -----           ------   ------           ------
    Income before income
     taxes                  53,873           65,113  111,215          134,784
    Provision (benefit)
     for income taxes       14,324           16,825 (61,120)           34,067
    Net income             $39,549          $48,288 $172,335         $100,717
                           =======          ======= ========         ========

    Net income per
     share:
      Basic                  $0.27            $0.34    $1.17            $0.71
                             =====            =====    =====            =====
      Diluted                $0.26            $0.33    $1.14            $0.70
                             =====            =====    =====            =====

    Shares used in
     computing per share
     amounts:
      Basic                148,890          143,275  147,860          142,562
                           =======          =======  =======          =======
      Diluted              152,482          145,421  151,635          144,024
                           =======          =======  =======          =======

    (1)  Synopsys' second quarter ended on the Saturday nearest April 30.
     For presentation purposes,  the Unaudited Consolidated Statements
     of Operations refer to a  calendar month end.
    (2)  For the three and six months ended April 30, 2009, Synopsys
    reclassifed $3.3 million and $5.9 million from upfront license to
    time-based licensed revenue to conform to the current year
    presentation which had no impact on total revenue.


                                    SYNOPSYS, INC.
                      Unaudited Consolidated Balance Sheets (1)
                       (in thousands, except par value amounts)

                                                    April 30,    October 31,
                                                       2010          2009
                                                   ----------   ------------
    ASSETS:
    Current assets:
      Cash and cash equivalents                       $669,431       $701,613
      Short-term investments                           409,023        466,713
                                                       -------        -------
               Total cash, cash equivalents and
                short-term investments               1,078,454      1,168,326
      Accounts receivable, net                         149,654        127,010
      Deferred income taxes                             70,229         73,453
      Income taxes receivable                           36,294         51,191
      Prepaid and other current assets                  45,263         43,820
                                                        ------         ------
              Total current assets                   1,379,894      1,463,800
    Property and equipment, net                        140,630        146,910
    Goodwill                                           998,910        932,691
    Intangible assets, net                             119,806         96,810
    Long-term deferred income taxes                    270,365        205,396
    Other long-term assets                              95,731         93,247
               Total assets                         $3,005,336     $2,938,854
                                                    ==========     ==========

    LIABILITIES AND STOCKHOLDERS' EQUITY:
    Current liabilities:
      Accounts payable and accrued
       liabilities                                    $186,802       $255,095
      Accrued income taxes                              28,024          5,508
      Deferred revenue                                 505,771        553,990
                                                       -------        -------
               Total current liabilities               720,597        814,593
    Long-term accrued income taxes                      88,132        157,354
    Other long-term liabilities                        100,220         88,002
    Long-term deferred revenue                          38,226         34,739
                                                        ------         ------
               Total liabilities                       947,175      1,094,688
    Stockholders' equity:
      Preferred stock, $0.01 par value:
       2,000 shares authorized; none
       outstanding                                           -              -
      Common stock, $0.01 par value: 400,000
       shares authorized; 149,802 and
          146,945 shares outstanding,
           respectively                                  1,498          1,469
      Capital in excess of par value                 1,512,888      1,500,166
      Retained earnings                                725,102        574,980
      Treasury stock, at cost: 7,463 and
       10,326 shares, respectively                    (165,266)      (228,618)
      Accumulated other comprehensive loss             (16,061)        (3,831)
                                                       -------         ------
               Total stockholders' equity            2,058,161      1,844,166
               Total liabilities and stockholders'
                equity                              $3,005,336     $2,938,854
                                                    ==========     ==========

    (1)  Synopsys' second quarter ended on the Saturday nearest April 30.
     For presentation purposes, the Unaudited Consolidated Balance
     Sheets refer to a calendar month end.


                                SYNOPSYS, INC.
             Unaudited Consolidated Statements of Cash Flows (1)
                                (in thousands)

                                                  Six Months Ended April
                                                             30,
                                                   ----------------------
                                                    2010               2009
                                                    ----               ----
     CASH FLOWS FROM OPERATING ACTIVITIES:
     Net income                                 $172,335           $100,717
     Adjustments to reconcile net income
      to net cash provided by operating
         activities:
          Amortization and depreciation           50,219             49,728
          Stock compensation                      30,704             28,803
          Allowance for doubtful accounts           (742)             2,723
          Write-down of long-term investments          -              2,960
          Gain on sale of investments             (2,420)              (324)
          Deferred income taxes                  (38,549)             7,612
          In-process research and development          -                600
          Net changes in operating assets and
           liabilities, net of
            acquired assets and liabilities:
             Accounts receivable                 (20,626)           (46,707)
             Prepaid and other current assets     11,373             (3,047)
             Other long-term assets               (3,997)              (617)
             Accounts payable and other
              liabilities                        (68,672)          (105,639)
             Accrued income taxes                (48,157)            (5,959)
             Deferred revenue                    (45,235)           (88,065)
                                                 -------            -------
          Net cash provided by (used in)
           operating activities                   36,233            (57,215)

     CASH FLOWS FROM INVESTING ACTIVITIES:
          Proceeds from sales and maturities of
           short-term investments                188,650            123,041
          Purchases of short-term investments   (131,748)          (119,227)
          Purchases of property and equipment    (13,793)           (14,734)
          Cash paid for acquisitions, net of
           cash acquired                        (130,872)           (27,333)
          Capitalization of software
           development costs                      (1,415)            (1,485)
          Net cash used in investing activities  (89,178)           (39,738)

     CASH FLOWS FROM FINANCING ACTIVITIES:
          Principal payments on capital leases    (1,346)              (984)
          Issuances of common stock               73,210             26,652
          Purchases of treasury stock            (50,257)                 -
          Net cash provided by financing
           activities                             21,607             25,668
     Effect of exchange rate changes on
      cash and cash equivalents                     (844)                52
     Net change in cash and cash
      equivalents                                (32,182)           (71,233)
     Cash and cash equivalents, beginning
      of period                                  701,613            577,632
     Cash and cash equivalents, end of
      period                                    $669,431           $506,399
                                                ========           ========

    (1)  Synopsys' second quarter ended on the Saturday nearest April 30.
     For presentation purposes, the Unaudited Consolidated Statements of
     Cash Flows refer to a calendar month end.



    INVESTOR CONTACT:
    Lisa L. Ewbank
    Synopsys, Inc.
    650-584-1901

    EDITORIAL CONTACT:
    Yvette Huygen
    Synopsys, Inc.
    650-584-4547
    yvetteh@synopsys.com

SOURCE Synopsys, Inc.

Recommend :
0
Partner Area
React to this article
 
Latest news on SYNOPSYS, INC.
1d ago SYNOPSYS, INC.: OCZ Technology Group Achieves First-Pass Silicon Success with D..
3d ago SYNOPSYS, INC.: Synopsys Delivers 2X Speedup for Implementing and Verifying Fun..
06/12 SYNOPSYS, INC.: Synopsys Announces Design Kit Optimized for All SoC Processor C..
06/11 SYNOPSYS, INC.: Synopsys Unveils New Synthesis-Based Test Technology Delivering..
06/03 SYNOPSYS, INC.: Synopsys Delivers Comprehensive Design Implementation Solution ..
05/29 SYNOPSYS, INC.: TSMC Certifies Synopsys' Digital and Custom Solutions for 16-nm..
05/29 SYNOPSYS, INC.: Synopsys Introduces Starter Kit for DesignWare ARC EM Processor..
05/23 SYNOPSYS, INC.: Synopsys Delivers VDK for Renesas RH850 MCUs
05/23 SYNOPSYS, INC.: Synopsys Plans Full Slate of Special Events at DAC 2013
05/22 SYNOPSYS, INC.: Synopsys Posts Financial Results for Second Quarter Fiscal Year..
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.